TITLE

Management of Solid-pseudopapillary Neoplasms of the Pancreas: a Comparison with Standard Pancreatic Neoplasms

AUTHOR(S)
Castro, S.; Singhal, D.; Aronson, D.; Busch, O.; Gulik, T.; Obertop, H.; Gouma, D.
PUB. DATE
May 2007
SOURCE
World Journal of Surgery;May2007, Vol. 31 Issue 5, p1130
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Solid-pseudopapillary neoplasms (SPNs) of the pancreas are increasingly diagnosed, but the exact surgical management in terms of extent of the resection is not well defined. Patients operated on in our hospital between January 1993 and March 2005 formed the study groups. From 659 consecutive resections for pancreatic neoplasms, 12 female patients (1.8%) with a median age of 21 years who underwent resection for (SPN) are compared with the remaining 647 pancreatic resection patients. Jaundice (SPN 0 versus PR 73%, p < 0.001) and weight loss (SPN 0 versus PR 49%, p = 0.001) occurred significantly less often. Neoplasms were distributed equally among the pancreatic head (SPN 5 out of 12 patients versus PR 88%, p < 0.001) and corpus/tail (SPN 6 out of 12 patients versus PR 8%, p < 0.001). The operative time was significantly shorter (SPN 233 min versus PR 280 min, p = 0.012), and there were significantly fewer complications (SPN 1 of 12 patients versus PR 48%, p = 0.007). The mortality was not different (SPN 0 versus PR 1.6%, p = 1.000), and the hospital stay was significantly shorter (SPN 9 days versus PR 15 days, p = 0.012). The median size of the neoplasms was significantly larger (SPN 6.9 cm versus PR 2.5 cm). The median number of lymph nodes harvested was significantly fewer (SPN 1 versus PR 6, p = 0.001), and lymph node metastases occurred significantly less often (SPN 0 versus PR 64%, p < 0.001). The 5-year survival of SPN patients was 100% and is significantly better compared with survival of patients with pancreatic adenocarcinoma (12%, p < 0.001) and ampulla of Vater adenocarcinoma (22%, p = 0.005). Patients with solid-pseudopapillary neoplasms of the pancreas present differently and the course of the disease is more benign. These patients can be adequately managed by pylorus-preserving pancreatoduodenectomy or spleen-preserving distal pancreatectomy with excellent early and long-term results.
ACCESSION #
24976651

 

Related Articles

  • Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Hoadley, Katherine A; Williams, Lindsay A; Kim, Hong Jin; Bentrem, David J; Yeh, Jen Jen; Moffitt, Richard A; Marayati, Raoud; Chung, Alexander H; Anderson, Judy M; Hollingsworth, Michael A; Talamonti, Mark S; Iacobuzio-Donahue, Christine A; Flate, Elizabeth L; Loeza, S Gabriela Herrera; Rashid, Naim U; Smyla, Jadwiga K; Volmar, Keith E; Eaton, Samuel C // Nature Genetics;Oct2015, Vol. 47 Issue 10, p1168 

    Pancreatic ductal adenocarcinoma (PDAC) remains a lethal disease with a 5-year survival rate of 4%. A key hallmark of PDAC is extensive stromal involvement, which makes capturing precise tumor-specific molecular information difficult. Here we have overcome this problem by applying blind source...

  • Pancreatic Endocrine Tumor Presenting with Obstructive Jaundice. Di Bisceglie, Adrian M.; Segal, Isidor; Mannell, Aylwyn; Posen, Jeffrey // American Journal of Gastroenterology;Jan1984, Vol. 79 Issue 1, p43 

    A case of obstructive jaundice is presented, resulting from a benign, nonfunctioning pancreatic endocrine tumor. The neoplasm was indistinguishable clinically, biochemically, and radiologically from adencarcinoma of the pancreas.

  • Three cases of pancreatic serous cystadenoma and endocrine tumour. Blandamura, Stella; Parenti, Anna; Famengo, Barbara; Canesso, Alessandra; Moschino, Paolo; Pasquali, Claudio; Pizzi, Sara; Guzzardo, Vincenza; Ninfo, Vito // Journal of Clinical Pathology;Mar2007, Vol. 60 Issue 3, p278 

    Aims: To report three cases of serous cystadenoma and endocrine tumour in the same pancreas, to review the literature and to evaluate the clinicopathalogical features of the tumours. Cases: Three women (71,57 and 31 years old) were admitted to hospital, two for diseases unrelated to the pancreas...

  • IMAGES IN MEDICINE: Sister Joseph's nodule. Clague, J. E. // Postgraduate Medical Journal;Mar2002, Vol. 78 Issue 917, p174 

    The article presents a picture of a umbilical lesion that was noted in an 82 year old man who presented with weight loss and abdominal pain. The lesion is known as a Sister Joseph's nodule. The lesion had been recognised previously and reported in publications from the mid-19th century. The...

  • Early Detection of Pancreatic Glucagonoma. Haga, Yoshio; Yanagi, Hidetaka; Urata, Jouji; Inada, Masayuki; Shimada, Shinya; Nitahata, Nagomu; Tanimura, Masanori // American Journal of Gastroenterology;Dec1995, Vol. 90 Issue 12, p2216 

    Glucagonoma is a rare islet cell tumor of pancreas. Only 122 proven cases have been reported in the English literature so far. Diagnosis of glucagonoma has usually been delayed. The average size of clinically detected glucagonomas was 5.8 cm, and 54.7% of them exhibited metastasis. We describe...

  • Expression of Plasminogen Activators and Their Inhibitors in Human Pancreatic Carcinoma: Immunohistochemical Study. Takeuchi, Yuuki; Nakao, Akimasa; Harada, Akio; Nonami, Toshiaki; Fukatsu, Toshiaki; Takagi, Hiroshi // American Journal of Gastroenterology;Nov1993, Vol. 88 Issue 11, p1928 

    Expression of plasminogen activators (PA), tissue type (t-PA) and urokinase type (t-PA), as well as PA inhibitors (PAI), type-1 (PAI-I) and type 2 (PAI-2), were investigated immunohistochemically in 97 human pancreatic carcinomas. u-PA expression predominated in pancreatic carcinomas, compared...

  • Solitary Metastatic Tumors to the Pancreas: A Case Report and Review of the Literature. Robbins, Earl G.; Franceschi, Dido; Barkin, Jamie S. // American Journal of Gastroenterology;Nov1996, Vol. 91 Issue 11, p2414 

    Secondary pancreatic tumors should be considered in those patients who present with a solitary pancreatic mass and who ave bad a previous nonpancreatic malignancy. The most common primary tumor origin of solitary pancreatic metastases is renal cell carcinoma, but many other primary sites have...

  • Pancreatic Neuroendocrine Tumors: Presentation, Management, and Outcomes. NISSEN, NICHOLAS N.; KIM, AMANDA S.; YU, RUN; WOLIN, EDWARD M.; FRIEDMAN, MARC L.; LO, SIMON K.; WACHSMAN, ASHLEY M.; COLQUHOUN, STEVEN D. // American Surgeon;Oct2009, Vol. 75 Issue 10, p1025 

    Pancreatic neuroendocrine tumors (pNETs) are an uncommon pancreatic neoplasm. We reviewed the presentation, management, and outcome of patients with pNETs treated at a single center by a multidisciplinary approach between 2004 and 2008. Over this time period, 154 patients with carcinoid and...

  • Tuberculosis of pancreas and peripancreatic lymph nodes: a case report. Taher, M. T.; Hashemi, S. M. H.; Mohammadi, M.; Hashemi, F. // Eastern Mediterranean Health Journal;nov/dic2009, Vol. 15 Issue 6, p1617 

    The article describes a case of pancreatic tuberculosis (TB) in a 51-year-old Iranian woman who presented with a pancreatic mass. Upon presentation, the woman complained of experiencing epigastric pain unrelated to meals, fever, anorexia and weight loss. The results of an exploratory surgery...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics